 |
| Welcome to the AWP Class Action Website Se Habla Español Por Favor Presione Aqui ***If you were administered the Astra Zeneca drug Zoladex www.astrazenecaawpsettlement.com ***If you were administered any of the other drugs listed There are class action lawsuits pending in the U.S. District Court for the District of Massachusetts. The litigation is called In re: Pharmaceutical Industry Average Wholesale Price Litigation, Docket No. 01-CV-12257-PBS. The lawsuits claim that certain drug companies intentionally reported false and inflated average wholesale prices (“AWP”) for certain types of outpatient drugs. The AWP’s are used to set the price that Medicare and consumers making Medicare Part B co-payments will pay for the drug. It also may be used to set the price paid for the drugs by Third-Party Payors. The lawsuits claim that as a result of Defendant’s actions consumers making Medicare Part B co-payments and some Third Party Payors paid more for the drugs at issue than they should have. (For a more detailed description of what Plaintiffs say about the claims in the lawsuit, click here). Defendants deny they did anything wrong. They say that AWP is an industry term of art and that everyone in the industry, including Medicare, understood that it did not reflect the acquisition cost of the drugs. They have other defenses that are explained more fully elsewhere on this website. (For a more detailed description of what Defendants say about the claims in the lawsuit, click here). The Court has not decided who is right in the lawsuits yet. The Court has certified certain classes of consumers and TPPs. The Court has certified that a series of trials and hearings will determine the claims in these lawsuits. An initial trial including all Defendants related to claims by TPPs will begin in November 2006. The first trial on March 5, 2007 at 9:00 a.m. has been rescheduled and will begin on April 30, 2007 at 9:00 a.m.
|
|||||||||||||||||||||||||||||||||||||